Interpretation of update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults (RANO 2.0) from the perspective of imaging medicine

REN Yan; YIN Bo; RUI Wenting; CHENG Haixia; HUANG Ruofan; QIN Zhiyong; WANG Yang; ZHANG Jiawen; YAO Zhenwei nbsp

doi:10.19732/j.cnki.2096-6210.2024.02.001

您当前的位置：

首页 >

文章列表页 >

Interpretation of update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults (RANO 2.0) from the perspective of imaging medicine

更新时间：2026-06-18

- Interpretation of update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults (RANO 2.0) from the perspective of imaging medicine
- Vol. 33, Issue 2, Pages: 101-107(2024)
- 作者机构：
  
  1. 复旦大学附属华山医院放射科,上海,200040
  2. 复旦大学附属华山医院病理科,上海,200040
  3. 复旦大学附属华山医院肿瘤科,上海,200040
  4. 复旦大学附属华山医院神经外科,上海,200040
  5. 复旦大学附属华山医院放疗中心,上海,200040
- 作者简介：
- 基金信息：
- DOI：10.19732/j.cnki.2096-6210.2024.02.001
  CLC：
- Online First：10 May 2024，
  
  Published：10 May 2024
- 稿件说明：
移动端阅览
任彦,尹波,芮文婷,等. 从影像医学的角度解读成人神经胶质瘤的神经肿瘤反应评价标准更新：RANO 2.0[J]. 肿瘤影像学, 2024, 33(2): 101-107 https://doi.

org/10.19732/j.cnki.2096-6210.2024.02.001
任彦,尹波,芮文婷,等. 从影像医学的角度解读成人神经胶质瘤的神经肿瘤反应评价标准更新：RANO 2.0[J]. 肿瘤影像学, 2024, 33(2): 101-107 https://doi. DOI： 10.19732/j.cnki.2096-6210.2024.02.001.

org/10.19732/j.cnki.2096-6210.2024.02.001 DOI：

摘要

神经肿瘤反应评价（response assessment in neuro-oncology，RANO）标准在临床试验和实践中被广泛使用。但

在使用过程中，不同的评估标准［高级别胶质瘤（high grade glioma，HGG）神经肿瘤评估标准（RANO-HGG）、改良

RANO（modified RANO，mRANO）和免疫治疗RANO（immunotherapy RANO，iRANO）］常导致临床疗效评估的差异，

也增加了究竟使用哪一套标准进行评估的不确定性。2023年9月RANO工作组针对所有神经胶质瘤制定了统一的新版神经肿

瘤反应评估标准（RANO 2.0）。磁共振成像是神经肿瘤治疗反应评估的主要检查手段，而随着神经肿瘤治疗方式的多样

化，神经肿瘤治疗反应的影像学表现也更加复杂。本文主要针对RANO 2.0的影像学部分进行介绍，目的是解析新版RANO

中关于磁共振成像评价的技术和诊断要点，旨在为影像医学在成人神经胶质瘤治疗反应评价中的合理应用提供帮助。

Abstract

The response assessment in neuro-oncology (RANO) criteria are widely used in clinical trials and practice. However

in the process of using RANO standards

various criteria of RANO-high grade glioma (RANO-HGG)

modified RANO (mRANO)and immunotherapy RANO (iRANO) lead to differences in the response assessment

and also increase the uncertainty of which set of criteria to be used for the clinical assessment. In September 2023

the RANO working group developed a new version of the update to the response assessment in neuro-oncology criteria for all gliomas in adults (RANO 2.0)

in which

magnetic resonance imaging (MRI) is the main examination method for the assessment of treatment response of neuro-oncology

and with the diversification of neuro-oncology treatment methods

the imaging manifestations of neuro-oncology treatment response are becoming more complex than before. This article introduced the core imaging contents with the detailed illustration of the technical and diagnostic key points in the MRI evaluation in the RANO 2.0

and aimed to provide help for the rational application of imaging medicine in the assessment of treatment response of adult gliomas.

关键词

Keywords

references

Views

478

下载量

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Prediction of triple-negative breast cancer via intratumoral and peritumoral ultrasound-based radiomics

From structure to function: evolution of magnetic resonance technology and transformation of imaging diagnosis

Comparative study of C-TIRADS, shear-wave elastography, and artificial intelligence in size-stratified diagnosis of thyroid nodules

Evaluation of neoadjuvant chemotherapy response for breast cancer with artificial intelligence assisted imaging ZHANG Nan1, ZHANG Yafang2, ZHOU Qi3

Conventional ultrasound combined with contrast-enhanced ultrasound in the diagnosis of hepatic tuberculous granuloma: a case report

Related Author

No data

Related Institution

No data

AI问答

⁰